Update on Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products

MHRA have made an update to the Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products. The update is to an expiry date for one of the batches in the recall. All other details remain the same.

Further information on the recall and update can be found here.